Narrow your search

Library

ULB (7)

ULiège (6)

KU Leuven (4)

VUB (3)

Odisee (2)

Thomas More Kempen (2)

Thomas More Mechelen (2)

UCLouvain (2)

UCLL (2)

VIVES (2)

More...

Resource type

book (11)


Language

English (8)

French (2)

German (1)


Year
From To Submit

2016 (11)

Listing 1 - 10 of 11 << page
of 2
>>
Sort by

Book
Non‐invasive prenatal testing (NIPT) for fetal sex determination : health technology assessment
Author:
Year: 2016 Publisher: Oslo, Norway : National Institute of Public Health, Division of Health Services,

Loading...
Export citation

Choose an application

Bookmark

Abstract

X-linked recessive diseases are severe hereditary diseases that are manifested solely in males. If the mother is a carrier of an X-linked recessive disease, she can either have a healthy girl, a healthy girl who is a carrier like the mother, a healthy boy, or a boy that becomes ill with the X-linked disease. Current practice in Norway is that all pregnant women at increased risk of having a child with an X-linked recessive disease, are eligible for an invasive test (chorionic villus sampling or amniocentesis), without any determination of the fetal sex beforehand. Annually, 40-60 invasive tests are performed in this group of pregnant women in Norway. In non-invasive prenatal testing (NIPT), a blood sample of the pregnant woman is used to identify fetal sex. The method is based on the analysis of cell-free fetal DNA found in maternal blood early in pregnancy. The purpose of using NIPT for fetal sex determination is to avoid unnecessary invasive testing of pregnant women who carry a female fetus. We have summarized research findings on NIPT's diagnostic accuracy for fetal sex determination, as well as discussed clinical, health economic and ethical consequences related to NIPT used for fetal sex determination. Based on the findings: 1. Diagnostic accuracy of NIPT for fetal sex determination is very high. 2. Maternal blood samples taken in gestational week 7 or later provide more reliable results than blood samples taken before week 7. 3. Assuming 50 pregnant women are tested every year, 21 of these will avoid invasive testing. 4. Introduction of a program where NIPT is used in determination of fetal sex, will increase the annual total health care cost expendings by 197,000 Norwegian kroner.


Book
Non-invasive prenatal test (NIPT) for identification of trisomy 21, 18 and 13 : health technology assessment
Author:
Year: 2016 Publisher: Oslo, Norway : National Institute of Public Health, Division of Health Services,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Currently, screening for trisomy (21,18 and 13) in Norway is based on a combination of blood tests and ultrasound (CUB) offered to all pregnant women 38 years of age or older. If the combined screening test indicates high risk, genetic verification via an invasive diagnostic test is offered either through chorionic villus sampling or amniocentesis. Non-Invasive Prenatal Testing (NIPT) measures the underlying genetic pathology of trisomies directly by analyzing fetal genetic material in the maternal circulation (cell-free fetal DNA, cffDNA). Several commercial testing strategies are available using different sequencing techniques for screening of trisomy 21, 18 and 13. We summarize research of diagnostic test accuracy of NIPT. In addition, we analyze health economic implications and highlight ethical consequences related to the national introduction of NIPT for detection of trisomy in pregnant women. Based on the evidence it seems that: 1. NIPT is a more accurate test for detecting trisomy than the CUB that is in use in Norway today. 2. A program with NIPT as a secondary test after CUB will result in fewer invasive tests and be more expensive than the current screening in Norway. 3. A program with NIPT as a primary test instead of CUB will also result in fewer invasive tests, but will be more expensive than both the current screening and if NIPT is used as secondary screeningtest. 4. NIPT is a test that challenges the underlying rationale for why and how we as a community and health service want to organize the fetal diagnostic services in Norway.


Book
Non-invasive prenatal test (NIPT) for identification of trisomy 21, 18 and 13 : health technology assessment
Author:
Year: 2016 Publisher: Oslo, Norway : National Institute of Public Health, Division of Health Services,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Currently, screening for trisomy (21,18 and 13) in Norway is based on a combination of blood tests and ultrasound (CUB) offered to all pregnant women 38 years of age or older. If the combined screening test indicates high risk, genetic verification via an invasive diagnostic test is offered either through chorionic villus sampling or amniocentesis. Non-Invasive Prenatal Testing (NIPT) measures the underlying genetic pathology of trisomies directly by analyzing fetal genetic material in the maternal circulation (cell-free fetal DNA, cffDNA). Several commercial testing strategies are available using different sequencing techniques for screening of trisomy 21, 18 and 13. We summarize research of diagnostic test accuracy of NIPT. In addition, we analyze health economic implications and highlight ethical consequences related to the national introduction of NIPT for detection of trisomy in pregnant women. Based on the evidence it seems that: 1. NIPT is a more accurate test for detecting trisomy than the CUB that is in use in Norway today. 2. A program with NIPT as a secondary test after CUB will result in fewer invasive tests and be more expensive than the current screening in Norway. 3. A program with NIPT as a primary test instead of CUB will also result in fewer invasive tests, but will be more expensive than both the current screening and if NIPT is used as secondary screeningtest. 4. NIPT is a test that challenges the underlying rationale for why and how we as a community and health service want to organize the fetal diagnostic services in Norway.


Book
Non‐invasive prenatal testing (NIPT) for fetal sex determination : health technology assessment
Author:
Year: 2016 Publisher: Oslo, Norway : National Institute of Public Health, Division of Health Services,

Loading...
Export citation

Choose an application

Bookmark

Abstract

X-linked recessive diseases are severe hereditary diseases that are manifested solely in males. If the mother is a carrier of an X-linked recessive disease, she can either have a healthy girl, a healthy girl who is a carrier like the mother, a healthy boy, or a boy that becomes ill with the X-linked disease. Current practice in Norway is that all pregnant women at increased risk of having a child with an X-linked recessive disease, are eligible for an invasive test (chorionic villus sampling or amniocentesis), without any determination of the fetal sex beforehand. Annually, 40-60 invasive tests are performed in this group of pregnant women in Norway. In non-invasive prenatal testing (NIPT), a blood sample of the pregnant woman is used to identify fetal sex. The method is based on the analysis of cell-free fetal DNA found in maternal blood early in pregnancy. The purpose of using NIPT for fetal sex determination is to avoid unnecessary invasive testing of pregnant women who carry a female fetus. We have summarized research findings on NIPT's diagnostic accuracy for fetal sex determination, as well as discussed clinical, health economic and ethical consequences related to NIPT used for fetal sex determination. Based on the findings: 1. Diagnostic accuracy of NIPT for fetal sex determination is very high. 2. Maternal blood samples taken in gestational week 7 or later provide more reliable results than blood samples taken before week 7. 3. Assuming 50 pregnant women are tested every year, 21 of these will avoid invasive testing. 4. Introduction of a program where NIPT is used in determination of fetal sex, will increase the annual total health care cost expendings by 197,000 Norwegian kroner.


Book
Avery's neonatology : pathophysiology and management of the newborn
Authors: ---
ISBN: 1496318684 9781496318688 9781451192681 1451192681 Year: 2016 Publisher: Philadelphia : Wolters Kluwer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This book aims to provide the pathophysiology and management of both preterm and full-term neonates.


Book
Surveillance fœtale pendant le travail
Authors: --- ---
ISSN: 1633972X ISBN: 9782294747229 2294747224 Year: 2016 Publisher: Issy-les-Moulineaux : Elsevier Masson,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Quatrième de couverture : "La surveillance du travail est un moment crucial pour la mère et l'enfant, situé au coeur de la pratique quotidienne des obstétriciens et des sages-femmes. Sa prise en charge, toujours particulière et souvent stressante, ne fait cependant pas toujours l'objet d'un consensus général en relevant alors de pratiques individuelles, parfois sources de iatrogénie avec risque d'augmentation de naissances opératoires. Cet ouvrage résolument pratique, rédigé par les meilleurs spécialistes, vous guide dans votre diagnostic, vous offre toutes les clés nécessaires à la définition d'une stratégie lors de la surveillance du travail, et vous aide dans vos prises de décision thérapeutique. Les premiers chapitres détaillent la chronologie des événements : admission en salle de naissance, surveillance des contractions, du rythme cardiaque foetal, du partogramme, place de l'échographie, surveillance par STAN, etc. Les cas plus spécifiques, tels la présentation par le siège, les grossesses multiples, l'obésité et l'utérus cicatriciel, font l'objet de chapitres dédiés. Enfin, les auteurs abordent deux points plus spécifiques : les répercussions sur le foetus et le RCF des thérapeutiques prescrites pendant le travail, et l'interprétation des mesures de pH et de lactates à la naissance."


Book
3D-Sonographie in der pränatalen Diagnostik
Author:
ISBN: 3110471531 3110471760 9783110471762 9783110471533 Year: 2016 Publisher: Berlin Boston

Loading...
Export citation

Choose an application

Bookmark

Abstract

Die dreidimensionale (3D) Ultraschalldiagnostik hat in den letzten Jahren die Geburtshilfe-Betreuung erobert, so dass heute mehr als die Hälfte der Kliniken und Praxen hierzulande ein 3D-fähiges Ultraschallgerät besitzen. Zunächst bekannt durch das "Baby-Facing", besitzt die 3D-Sonografie inzwischen jedoch ein viel größeres Potential in der Darstellung der verschiedenen Organe unter normalen und pathologischen Bedingungen. Dabei können viele Funktionen wie eine neu zu erlernende Software bedient werden. Dieses Werk versteht sich zum Einen als praktischer Leitfaden, um die vielen 3D-Funktionen zu erläutern. Zum Anderen soll es eine Hilfestellung liefern, die 3D-Sonografie im Rahmen einer gezielten vorgeburtlichen Diagnostik optimal anzuwenden. Die Autoren verfügen über 15 Jahre Erfahrungen auf dem Gebiet der 3D-Sonografie.


Book
Medical genetics
Authors: --- ---
ISBN: 9780323188357 Year: 2016 Publisher: Philadelphia, Pa Elsevier


Book
In-Vitro Diagnostic Devices : Introduction to Current Point-of-Care Diagnostic Devices
Authors: --- ---
ISBN: 3319197363 3319197371 Year: 2016 Publisher: Cham : Springer International Publishing : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Addressing the origin, current status, and future development of point-of-care diagnostics, and serving to integrate knowledge and tools from Analytical Chemistry, Bioengineering, Biomaterials, and Nanotechnology, this book focusses on addressing the collective and combined needs of industry and academia (including medical schools) to effectively conduct interdisciplinary research. In addition to summarizing and detailing developed diagnostic devices, this book will attempt to point out the possible future trends of development for point-of-care diagnostics using both scientifically based research and practical engineering needs with the aim to help novices comprehensively understand the development of point-of-care diagnostics. This includes demonstrating several common but critical principles and mechanisms used in point-of-care diagnostics that address practical needs (e.g., disease or healthcare monitoring) using two well-developed examples so far: 1) blood glucose meters (via electrochemistry); and, 2) pregnancy tests (via lateral flow assay). Readers of this book will come to fully comprehend how to develop point-of-care diagnostics devices, and will be inspired to contribute to a critical global cause – the development of inexpensive, effective, and portable in vitro diagnostics tools (for any purpose) that can be used either at home or in resource limited areas.

Listing 1 - 10 of 11 << page
of 2
>>
Sort by